Myomo (NYSEAMERICAN:MYO) Director Joseph Jr. Manko Buys 30,367 Shares

Myomo, Inc. (NYSEAMERICAN:MYO) Director Joseph Jr. Manko acquired 30,367 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The shares were purchased at an average cost of $0.89 per share, for a total transaction of $27,026.63. Following the completion of the transaction, the director directly owned 2,309,775 shares in the company, valued at $2,055,699.75. The trade was a 1.33% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Myomo Stock Performance

Shares of NYSEAMERICAN MYO traded down $0.07 during trading on Monday, reaching $0.84. 429,115 shares of the company traded hands, compared to its average volume of 419,367. The firm has a 50 day simple moving average of $0.76 and a 200-day simple moving average of $0.85. The company has a quick ratio of 2.36, a current ratio of 2.73 and a debt-to-equity ratio of 1.21. The stock has a market capitalization of $32.42 million, a PE ratio of -2.33 and a beta of 1.39. Myomo, Inc. has a 52-week low of $0.61 and a 52-week high of $3.45.

Analysts Set New Price Targets

Separately, Craig Hallum reaffirmed a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $7.67.

Institutional Trading of Myomo

A number of institutional investors have recently made changes to their positions in MYO. Rosalind Advisors Inc. boosted its holdings in shares of Myomo by 33.0% during the 2nd quarter. Rosalind Advisors Inc. now owns 3,595,788 shares of the company’s stock valued at $7,767,000 after acquiring an additional 892,127 shares during the last quarter. Jefferies Financial Group Inc. purchased a new position in shares of Myomo in the fourth quarter worth approximately $641,000. Geode Capital Management LLC boosted its holdings in shares of Myomo by 160.8% in the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock worth $1,446,000 after buying an additional 412,631 shares during the last quarter. Centiva Capital LP purchased a new position in shares of Myomo in the third quarter worth approximately $190,000. Finally, Prescott Group Capital Management L.L.C. purchased a new position in shares of Myomo in the fourth quarter worth approximately $169,000. Hedge funds and other institutional investors own 44.99% of the company’s stock.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.